Jan 13, 2014
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.50 to $0.03.
The split itself did not change the total investment value.
Heron Therapeutics, Inc. (HRTX) trades on the NASDAQ Capital Market in the Biotechnology industry.
Heron Therapeutics, Inc. company overviewThe latest split shown was on January 13, 2014. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records 2 reverse splits between May 25, 2007 and January 13, 2014.